MWA CONSULTING, INC.
  • Home
  • About MWA
  • Consulting Services
  • Industry News
  • Webinars & Podcasts
  • Consulting Opportunities
  • Contact
  • Privacy Policy
Select Page

Inspection of Injectable Products for Visible Particulates: Draft Guidance for Industry

Dec 22, 2021

FROM THE INTRODUCTION: Visible particulates in injectable products can jeopardize patient safety. This guidance addresses the development and implementation of a holistic, risk-based approach to visible particulate control that incorporates product development,...

Are you staying current with FDA regulatory news and compliance trends?

Click here to sign up for MWA’s News You Can Use – it’s fast and free!

Recent Posts

  • FDA Proposed Rule: Quality System Regulation Amendment
  • Center for Devices and Radiological Health (CDRH) Issues 2022-2025 Strategic Priorities
  • Remote Auditing: Three Keys to Success
  • Inspection of Injectable Products for Visible Particulates: Draft Guidance for Industry
  • FDA Announces Availability of Portal and draft Guidance on Reporting Amount of Listed Drugs and Biological Products

Designed by Elegant Themes | Powered by WordPress